Imatinib Mesylate IP CAS NO. 220127-57-1
View 1

Imatinib Mesylate IP CAS NO. 220127-57-1

INR 20000.00

Sold By:  AVD Pharmaceuticals Private Limited

Verified Supplier

500+

Min. Order

7 Days

Delivery

PAN India

Supply Area

Product Specifications

Grade Standard IP
API Name Imatinib Mesylate IP
Pharmacopoeial Grade IP
Purity Greater than 99%
Chemical Formula C29H31N7O
Packaging Size 1 kg
Dosage Form Use Injection
Molecular Weight 493.6 g/mol
Physical Form Powder
Therapeutic Class Anticancer
Manufacturing Route Synthetic
Packaging Type HDPE Bag
Appearance Slightly yellowish Powder

Preferred Buyer From: All over the world

Product Overview

Imatinib, also known by synonyms such as Imatinib Mesylate, STI-571, and Gleevec, is a targeted tyrosine kinase inhibitor primarily used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by selectively blocking the BCR-ABL fusion protein and other tyrosine kinases responsible for uncontrolled cancer cell proliferation, offering high efficacy with reduced toxicity compared to conventional chemotherapy. About the Company GST Registration Date: 2022 Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 1.5 - 5 Cr

Interested in this product?

Ask for more details & Latest Price from seller

AVD Pharmaceuticals Private Limited

Pune, Maharashtra, India, Pune, Maharashtra

Nature of Business

N/A

GST No.

*****

Address

Pune, Maharashtra, India, Pune, Maharashtra

To Get Instant Response

Post Your Requirement

By clicking Submit, I accept the T&C and Privacy Policy .

Why Buy Through B2B India

Verified Supplier

Direct Seller Communication

Best Price Guarantee